BRIEF published on 05/08/2025 at 05:05, 7 days 13 hours ago Adtran Networks SE publie ses résultats financiers préliminaires du premier trimestre 2025 Croissance Des Revenus Rapports Financiers Réseaux Adtran Résultats Du Premier Trimestre 2025 EBIT Pro Forma
BRIEF published on 05/08/2025 at 05:05, 7 days 13 hours ago Adtran Networks SE Reports Q1 2025 Preliminary Financial Results Revenue Growth Financial Reporting Adtran Networks Pro Forma EBIT Q1 2025 Results
PRESS RELEASE published on 05/08/2025 at 05:00, 7 days 14 hours ago Adtran Networks SE announces preliminary results for Q1 2025 Adtran Networks SE reports preliminary results for Q1 2025: Revenue up 4.1% year-over-year to EUR 114.1 million, Pro forma EBIT at negative EUR 4.8 million. For more information visit www.adva.com Financial Results Revenue EBIT Adtran Networks SE Q1 2025
BRIEF published on 04/15/2025 at 21:56, 29 days 21 hours ago Adtran Networks SE révise ses prévisions financières pour 2024 Résultats Financiers 2024 Ajustement Des Stocks Réseaux Adtran Perte Attendue EBIT Pro Forma IFRS
BRIEF published on 04/15/2025 at 21:56, 29 days 21 hours ago Adtran Networks SE Revises 2024 Financial Expectations Adtran Networks Financial Results 2024 Inventory Adjustment Expected Loss IFRS Pro Forma EBIT
PRESS RELEASE published on 04/15/2025 at 21:51, 29 days 21 hours ago EQS-Adhoc: Adtran Networks SE updates preliminary results for the financial year 2024 Adtran Networks SE updates preliminary results for the financial year 2024, expecting a loss due to inventory adjustment. Full financial statements to be published on April 30, 2025 Preliminary Results Financial Year 2024 Adtran Networks SE Loss Inventory Adjustment
BRIEF published on 02/27/2025 at 05:05, 2 months 16 days ago Adtran Networks SE Announces Q4 and FY 2024 Financial Results EBIT Loss Gross Margin Improvement Q4 2024 Revenues Annual Revenue Decline Financial Statements Publication
BRIEF published on 02/27/2025 at 05:05, 2 months 16 days ago Adtran Networks SE annonce ses résultats financiers du quatrième trimestre et de l'exercice 2024 Perte EBIT Amélioration De La Marge Brute Chiffre D'affaires Du Quatrième Trimestre 2024 Baisse Des Revenus Annuels Publication Des États Financiers
PRESS RELEASE published on 02/27/2025 at 05:00, 2 months 16 days ago Adtran Networks SE announces preliminary results for Q4 2024 and fiscal year 2024 Adtran Networks SE announces preliminary results for Q4 2024 and fiscal year 2024 with a 0.4% increase in Q4 2024 revenues and a full-year revenue decrease of 28.6% in 2024 Preliminary Results Fiscal Year 2024 Revenue Decrease Adtran Networks SE Q4 2024
BRIEF published on 11/07/2024 at 07:00, 6 months 8 days ago Adtran Networks SE Reports Q3 2024 Financial Results Revenue Decline Net Loss Cash Flow Improvement Future Outlook Q3 2024 Financial Results
Published on 05/15/2025 at 17:55, 1 hour 7 minutes ago Spetz Retracts and Clarifies its News Release From May 14th
Published on 05/15/2025 at 16:30, 2 hours 32 minutes ago Namibia Critical Metals Announces Results of Annual General Meeting of Shareholders
Published on 05/15/2025 at 16:25, 2 hours 37 minutes ago Trifecta Gold Announces Closing of $5.3 Million Private Placement with Lead Order from Crescat
Published on 05/15/2025 at 15:00, 4 hours 2 minutes ago Virexit Technologies, Inc. Secures Direct U.S. Rights to Distribute Airros(TM) Sanitation System
Published on 05/15/2025 at 15:00, 4 hours 2 minutes ago ACCESS Newswire to Present at Sidoti Micro-Cap Virtual Conference on May 21, 2025 at 10:00 a.m. ET
Published on 05/15/2025 at 18:36, 25 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 05/15/2025 at 18:29, 32 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/15/2025 at 18:11, 50 minutes ago bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy
Published on 05/15/2025 at 18:10, 51 minutes ago Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)
Published on 05/15/2025 at 18:10, 52 minutes ago M-KOPA Ranks Amongst the Financial Times’ Fastest Growing Companies in Africa for the Fourth Consecutive Year
Published on 05/15/2025 at 18:07, 54 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 05/15/2025 at 17:45, 1 hour 17 minutes ago Aéroports de Paris SA - Chairman & CEO remuneration
